
|Articles|June 1, 2008
- Pharmaceutical Executive-06-01-2008
- Volume 0
- Issue 0
John Orwin, Genentech
S
Advertisement
ONE TO WATCH:
John Orwin, SVP, Sales and Marketing, BioOncology, Genentech
Orwin learned the landscape of onoclogy while working as senior director of oncology marketing at Alza, and then eventually as the franchise VP at J&J's Tibotec division. In 2005, he headed out to Cali to join Genentech, and was promoted the same year to head sales and marketing of its BioOncology division. And it's a good thing: Orwin was part of the commercial genius that built such heavyweights as Avastin, Herceptin, and Rituxan.
Articles in this issue
over 18 years ago
Mary Szela, Abbottover 18 years ago
Mightier Than the Swordover 18 years ago
Keeshia Muhammad, Teva Specialty Pharmaceuticalsover 18 years ago
Eric Floyd, Cephalonover 18 years ago
Nancy Phelan, Wyethover 18 years ago
Tightening the Chainover 18 years ago
Kurt Graves, Vertexover 18 years ago
Wendy Niebler, Shireover 18 years ago
Perfectly ImperfectAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
Novartis, Bristol Myers Pause Autoimmune CAR-T Trials Over Safety Concerns: Report
2
Pharmaceutical Executive Daily: FDA Approves Zanvastro
3
Your Questions Answered: The Biggest Pharma and Biotech Stories This Week
4
FDA Approves Zanvastro for Alexander Disease in Pediatrics & Adults
5




